Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumour types
A pair of medications that make malignant cells act as if they have a virus…
Browsing: EZH2
Uterine cancer drug gets fast-track approval
A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug…
Scientists uncover a new approach for treating aggressive cancer
Researchers at the University of North Carolina at Chapel Hill and the UNC Lineberger Comprehensive…
Drug-like molecule points to novel strategies for cancer therapy
A decade ago, genome sequencing revealed a big surprise: about 50 percent of human cancers…
Bone microenvironment fosters breast cancer metastatic behaviour
Two studies led by Baylor College of Medicine, USA, shed new light on the unanswered…
Study: New approach may boost prostate cancer immunotherapies
Researchers have discovered a new way to transform the tissues surrounding prostate tumours to help…
Metabolic response behind reduced cancer cell growth
Researchers from Uppsala University in Sweden show in a new study that inhibition of the…
Researchers discover enzyme’s role in ‘natural killer T cell lymphoma’
Natural killer T cell lymphoma (NKTL) is an aggressive form of cancer with very poor…
Targeted therapy that can help children with deadly nerve cancer
Mount Sinai researchers have identified a targeted therapy for adolescent patients with neuroblastoma, a deadly…